{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:21:53Z","timestamp":1792790513973,"version":"4.5.0"},"reference-count":68,"publisher":"Informa UK Limited","issue":"5","license":[{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Merck & Co., Inc"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Human Vaccines &amp; Immunotherapeutics"],"published-print":{"date-parts":[[2022,11,30]]},"DOI":"10.1080\/21645515.2022.2054602","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T13:29:26Z","timestamp":1650547766000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":29,"title":["Burden of vaccine-preventable diseases among at-risk adult populations in the US"],"prefix":"10.1080","volume":"18","author":[{"given":"Irina","family":"Kolobova","sequence":"first","affiliation":[{"name":"Center for Observational and Real World Evidence, Merck &amp; Co., Inc., Kenilworth, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mawuli Kwame","family":"Nyaku","sequence":"additional","affiliation":[{"name":"Center for Observational and Real World Evidence, Merck &amp; Co., Inc., Kenilworth, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Karakusevic","sequence":"additional","affiliation":[{"name":"Adelphi Values PROVE, Bollington, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisy","family":"Bridge","sequence":"additional","affiliation":[{"name":"Adelphi Values PROVE, Bollington, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Fotheringham","sequence":"additional","affiliation":[{"name":"Adelphi Values PROVE, Bollington, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"O'Brien","sequence":"additional","affiliation":[{"name":"Center for Observational and Real World Evidence, Merck &amp; Co., Inc., Kenilworth, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,4,21]]},"reference":[{"key":"e_1_3_4_2_1","unstructured":"AJMC Peer Exchange. Assessing the cost of vaccine-preventable diseases; 2021 [accessed 2021 Mar 28]. https:\/\/www.ajmc.com\/journals\/supplement\/2020\/new-directions-immunization-awareness-engagement\/assessing-the-cost-of-vaccinepreventable-diseases"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.03.046"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10935-015-0394-3"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.09.016"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/14760584.2018.1527690"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.3402\/jmahp.v3403.27041"},{"key":"e_1_3_4_10_1","volume-title":"Implementing a life-course approach to immunization","author":"Morris T","year":"2019","unstructured":"Morris T, Tate J, Wait S, Scrutton J. Implementing a life-course approach to immunization. The Health Policy Partnership; 2019."},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-015-0708-7"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1086\/671271"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/risa.12854"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ387"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1665-2681(19)30927-5"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tmaid.2018.04.001"},{"issue":"3","key":"e_1_3_4_18_1","article-title":"Prevalence of viral hepatitis B and C infection among immigrants in the Baltimore-Washington metropolitan area screened from 2009-2014","volume":"25","author":"Ha E","year":"2016","unstructured":"Ha E, Kim F, Pan J, Hong DTP, Juon HS. Prevalence of viral hepatitis B and C infection among immigrants in the Baltimore-Washington metropolitan area screened from 2009-2014. Cancer Epidemiol Biomarkers Prev. 2016;25(3).","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10903-009-9239-6"},{"key":"e_1_3_4_20_1","first-page":"99","article-title":"Emerging viral infections in 21st century and their implications on health system","volume":"24","author":"Mishra AC","year":"2013","unstructured":"Mishra AC. Emerging viral infections in 21st century and their implications on health system. Indian J Virol. 2013;24:99\u2013100.","journal-title":"Indian J Virol"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-14-0491"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044611"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1086\/653622"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10903-016-0507-y"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis927"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10903-018-0705-x"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10903-009-9237-8"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.7326\/M17-1106"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v17.i14.1807"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2013.10.024"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1086\/649885"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000142"},{"key":"e_1_3_4_33_1","article-title":"Prevalence and outcomes of HIV-associated opportunistic pneumonias in the ERA of combination antiretroviral therapy","volume":"185","author":"Fong S","year":"2012","unstructured":"Fong S, Tokman S, Jarlsberg L, et al. Prevalence and outcomes of HIV-associated opportunistic pneumonias in the ERA of combination antiretroviral therapy. Am J Respir Crit Care Med. 2012;185(MeetingAbstracts).","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2019.05.047"},{"key":"e_1_3_4_35_1","first-page":"266","article-title":"Incidence of, and risk factors for herpes zoster in the haart era: an analysis of the chorus cohort","volume":"22","author":"Guignard AP","year":"2013","unstructured":"Guignard AP, Haguined F, St Laurent S, Vannappagari V. Incidence of, and risk factors for herpes zoster in the haart era: an analysis of the chorus cohort. Pharmacoepidemiol Drug Saf. 2013;22:266\u201367.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-016-9920-1"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.5664"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy087"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3181f70253"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pvr.2017.06.006"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0143698"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.7326\/M17-1689"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3326-z"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000822"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-160-1-201401070-00731"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2016.0165"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw067"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.21037\/tcr.2016.10.66"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1008880"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000866"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.09.008"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofw172.1892"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-12-0815"},{"key":"e_1_3_4_54_1","article-title":"Herpes zoster risk in immunocompromised adults in the United States: a systematic review","author":"McKay SL","year":"2019","unstructured":"McKay SL, Guo A, Pergam SA, Dooling K. Herpes zoster risk in immunocompromised adults in the United States: a systematic review. Clin Infect Dis: An Off Publ Infect Dis Soc Am. 2019.","journal-title":"Clin Infect Dis: An Off Publ Infect Dis Soc Am"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2012.10.027"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2015.10.031"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12473"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa298"},{"key":"e_1_3_4_59_1","doi-asserted-by":"publisher","DOI":"10.1177\/000313481908500744"},{"key":"e_1_3_4_60_1","volume-title":"Combating the silent epidemic of viral hepatitis: action plan for the prevention, care, and treatment of viral hepatitis","author":"US Department of Health Human Services","year":"2011","unstructured":"US Department of Health Human Services. Combating the silent epidemic of viral hepatitis: action plan for the prevention, care, and treatment of viral hepatitis. Washington, DC: US Department of Health and Human Services; 2011."},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0000000000000408"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1089\/apc.2018.0276"},{"key":"e_1_3_4_63_1","article-title":"Effect of opioid abuse and dependence on outcomes of patients hospitalized with pneumonia: a 5-year propensity score matched analysis","volume":"197","author":"Vazquez De Lara F","year":"2018","unstructured":"Vazquez De Lara F, Bolivar F, Pan D, Santibanez V, Mathew JP. Effect of opioid abuse and dependence on outcomes of patients hospitalized with pneumonia: a 5-year propensity score matched analysis. Am J Respir Crit Care Med. 2018;197(MeetingAbstracts).","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix438"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-016-1432-4"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.08.080"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/hsc.12857"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-015981"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2020.06.019"},{"key":"e_1_3_4_70_1","volume-title":"AHRQ methods for effective health care","author":"Dn GR","year":"2014","unstructured":"Dn GR, Leavy MB. Registries for evaluating patient outcomes: a user\u2019s guide [Internet]. In: Gliklich R; Dreyer N, Leavy M, editors. AHRQ methods for effective health care. Vol. 13(14). Rockville (MD): Agency for Healthcare Research and Quality (US); 2014. p. 1\u2013426."},{"key":"e_1_3_4_72_1","unstructured":"Adult Immunization: Shots to Save Lives [press release]; 2010."},{"key":"e_1_3_4_73_1","unstructured":"Centers for Disease Control and Prevention. Recommended adult immunization schedule for ages 19 years or older; 2021 [accessed 2021 Sep 21]. https:\/\/www.cdc.gov\/vaccines\/schedules\/hcp\/imz\/adult.html"}],"container-title":["Human Vaccines &amp; Immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/21645515.2022.2054602","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T16:18:07Z","timestamp":1707149887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/21645515.2022.2054602"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,21]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,11,30]]}},"alternative-id":["10.1080\/21645515.2022.2054602"],"URL":"https:\/\/doi.org\/10.1080\/21645515.2022.2054602","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=khvi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-12-22","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-04-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"2054602"}}